{
  "schema": "aibast-canonical-transcripts/1.0",
  "captured_at": "2026-10-07T01:43:14.021210+00:00",
  "solution": "@aibast-agents-library/contract-risk-review",
  "onepager": "Contract Risk Review Agent one-pager.pptx",
  "brainstem_version": "0.6.16",
  "loaded_tools_after_capture": [
    "ContractRiskReviewAgent"
  ],
  "agent_sources": [
    {
      "path": "agents/@aibast-agents-library/professional_services_stacks/contract_risk_review_stack/contract_risk_review_agent.py",
      "sha256": "31642fc92a4f7050b2a0050389d57d6ced4863aaf6e4a086a4e09979d832d9db"
    }
  ],
  "case_file": "tests/demo_cases/contract-risk-review.json",
  "case_file_sha256": "54c7725b362fa323b6d3f78467fe10430a1d68244eb0f22998be0897f54aef0a",
  "strict_isolation": true,
  "transcripts": [
    {
      "case_id": "CRR-01",
      "persona": "Legal Operations Director",
      "onepager_promise": "Perform comprehensive contract analysis to accelerate reviews and highlight critical risks",
      "prompt": "Which agreements should I put in front of counsel first, and what is driving the priority?",
      "assistant_response": "Priority order for counsel:\n\n1. **CTR-5001 \u2014 NovaTech Systems MSA** ($25M, risk 6.5/10, 4 HIGH issues) \u2014 top priority. Highest dollar exposure and the most high-severity issues; flagged for critical terms renegotiation at the Year-2 review.\n2. **CTR-5003 \u2014 Atlas Financial Group MSA** ($12M, risk 5.2/10, 1 HIGH issue) \u2014 second priority, with risk clauses needing resolution before its Dec 2027 renewal.\n3. **CTR-5004 \u2014 Orion Defense IDIQ** ($8.5M, risk 4.1, 0 HIGH) \u2014 lower urgency, long runway to 2030.\n4. **CTR-5002 \u2014 Meridian Healthcare SOW** ($4.2M, risk 3.8, 0 HIGH) \u2014 lowest urgency, nearest renewal but smallest exposure.\n\nWhat's driving the ranking: combined **risk score + number of HIGH-severity issues + dollar exposure**, not just renewal proximity \u2014 that's why NovaTech jumps ahead of Meridian despite renewing later. Want the clause-level breakdown for NovaTech or Atlas next?",
      "agent_logs": "[ContractRiskReviewAgent] ## Contract Risk Scan\n\n> Synthetic portfolio snapshot: 2026-03-17.\n**Active contracts:** 4\n**Total contract value:** $49,700,000\n**Value at elevated risk (score >= 5.0):** $37,000,000\n\n| Contract | Client | Type | Value | Term | Risk Score | HIGH Issues |\n|----------|--------|------|-------|------|------------|-------------|\n| CTR-5001 | NovaTech Systems | Master Services Agreement | $25,000,000 | 36mo | 6.5/10 | 4 |\n| CTR-5003 | Atlas Financial Group | Master Services Agreement | $12,000,000 | 24mo | 5.2/10 | 1 |\n| CTR-5004 | Orion Defense Systems | IDIQ Task Order | $8,500,000 | 60mo | 4.1/10 | 0 |\n| CTR-5002 | Meridian Healthcare | Statement of Work | $4,200,000 | 18mo | 3.8/10 | 0 |\n\n### Upcoming Renewals\n\n| Contract | Client | Renewal Date | Days Out | Action |\n|----------|--------|-------------|----------|--------|\n| CTR-5002 | Meridian Healthcare | 2027-09-15 | 547 | Begin renewal discussions Q1 2027 |\n| CTR-5003 | Atlas Financial Group | 2027-12-01 | 624 | Address risk clauses before renewal |\n| CTR-5001 | NovaTech Systems | 2028-06-30 | 835 | Renegotiate critical terms at Year-2 review |\n| CTR-5004 | Orion Defense Systems | 2030-03-31 | 1474 | Option-year review in 2028 |\n\n> Review support only; contract decisions require authorized legal counsel.",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "NovaTech Systems",
        "Atlas Financial Group",
        "Review support only"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-02",
      "persona": "Commercial Attorney",
      "onepager_promise": "Evaluate liability exposure and IP provisions to identify gaps and ensure complete financial protections",
      "prompt": "Walk me through the liability, IP ownership, and payment-term language that needs attention in the MSA.",
      "assistant_response": "Here's the breakdown on the three you flagged:\n\n**Liability (\u00a77.1) \u2014 HIGH**\nCap is tied to fees paid in the preceding 12 months (roughly $2\u20138M), with no carve-outs for IP infringement, data breach, or gross negligence \u2014 those should sit outside any cap. Push for a $10M cap with explicit carve-outs; fallback is $8.3M (annual contract value).\n\n**IP Ownership (\u00a78.2) \u2014 HIGH**\nAll work product \u2014 including improvements and derivatives \u2014 gets assigned to the client, with no protection for your pre-existing IP. Need a carve-out preserving ownership of pre-existing IP, plus a license-back for anything NovaTech-specific you build on top of it.\n\n**Payment Terms (\u00a79.4) \u2014 MEDIUM**\nNet 60 vs. your standard Net 30, which creates roughly $1.4M of cash-flow drag over the contract. Push to renegotiate to Net 30.\n\nRelated items worth bundling into the same conversation: \u00a77.3 indemnification is one-sided (you indemnify them, not vice versa) and \u00a712.1 termination has no cure period \u2014 both reinforce the liability risk above. Want the full negotiation positions/fallbacks for these, or the counsel escalation list?",
      "agent_logs": "[ContractRiskReviewAgent] ## Clause-Level Risk Analysis\n\n### CTR-5001 -- NovaTech Systems ($25,000,000)\n\n| Section | Clause | Risk | Issue | Recommendation |\n|---------|--------|------|-------|----------------|\n| 7.1 | Liability Cap | **HIGH** | Cap limited to fees paid in preceding 12 months ($2-8M range); no carve-outs for IP or data breach | Increase cap to $10M with carve-outs (IP indemnity, data breach, gross negligence); fallback minimum $8.3M (annual contract value) |\n| 8.2 | IP Ownership | **HIGH** | All work product assigned to client including improvements and derivatives; no pre-existing IP protection | Carve out pre-existing IP; add license-back for client-specific derivatives |\n| 9.4 | Payment Terms | **MEDIUM** | Net 60 days vs company standard Net 30; creates $1.4M cash-flow delay | Change to Net 30 payment terms |\n| 12.1 | Termination | **HIGH** | Client may terminate immediately for any breach with no cure period | Add 30-day cure period for termination |\n| 14.3 | SLA Penalties | **MEDIUM** | Penalties uncapped; could exceed monthly fees in extreme scenarios | Cap SLA penalties at 10% of monthly fees |\n| 15.2 | Change Orders | **MEDIUM** | Verbal change approvals accepted; creates scope-creep exposure | Require written change orders signed by authorized representatives |\n| 7.3 | Indemnification | **HIGH** | One-sided: we indemnify the client, the client does not indemnify us | Add mutual indemnification |\n| 16.1 | Dispute Resolution | **MEDIUM** | Litigation-first with no executive escalation or mediation step; high legal costs | Add escalation before litigation |\n| 3.2 | Auto-Renewal | **MEDIUM** | Auto-renews with an unfavorable rate lock preventing price adjustments | Remove auto-renewal |\n| 5.4 | Resource Replacement | **MEDIUM** | Client has unilateral right to replace our team members | Limit resource replacement rights |\n\n**Summary:** 4 HIGH, 6 MEDIUM risk clauses\n\n> Synthetic clause excerpts; findings are not legal advice or a complete contract opinion.",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "Liability Cap",
        "IP Ownership",
        "Payment Terms"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-03",
      "persona": "Legal Operations Manager",
      "onepager_promise": "Evaluate liability exposure and IP provisions to identify gaps and ensure complete financial protections",
      "prompt": "Compare the available contract evidence with our internal policy and tell me where the file is incomplete.",
      "assistant_response": "Here's where the evidence falls short of policy:\n\n**CTR-5001 (NovaTech) \u2014 10 gaps found, clause text present:**\n- Liability cap, IP ownership, payment terms, termination cure period, SLA penalties, change orders, indemnification, dispute resolution, auto-renewal, and resource replacement all deviate from policy standards (details above).\n\n**CTR-5002 (Meridian Healthcare) \u2014 file incomplete:** No clause evidence packaged at all \u2014 can't assess compliance until clause text is provided.\n\n**CTR-5003 (Atlas Financial) \u2014 3 gaps found:** Indemnification, data destruction, and non-compete language need fixes.\n\n**CTR-5004 (Orion Defense) \u2014 file incomplete:** Same issue as Meridian \u2014 no clause evidence available to review.\n\n**Bottom line:** CTR-5002 and CTR-5004 are the incomplete files \u2014 no compliance conclusion is possible until their clause data is added to the portfolio. Want me to pull the full renegotiation brief for CTR-5001 or CTR-5003 instead, since those have enough evidence to act on?",
      "agent_logs": "[ContractRiskReviewAgent] ## Compliance Check Results\n\n### Internal Policy Requirements\n\n| Requirement | Policy Standard |\n|-------------|----------------|\n| Liability Cap Minimum | $8,300,000 (annual contract value) |\n| Payment Terms Max Days | Net 30 |\n| Ip Preexisting Protection | Required |\n| Mutual Indemnification | Required |\n| Cure Period Days | 30 days |\n| Data Destruction Clause | Required |\n| Change Order Written | Required |\n| Sla Penalty Cap Pct | 10% of monthly fees |\n\n### Contract Compliance Status\n\n#### CTR-5001 -- NovaTech Systems -- **GAPS FOUND (10)**\n\n| Clause | Section | Severity | Required Action |\n|--------|---------|----------|-----------------|\n| Liability Cap | 7.1 | HIGH | Increase cap to $10M with carve-outs (IP indemnity, data breach, gross negligence); fallback minimum $8.3M (annual contract value) |\n| IP Ownership | 8.2 | HIGH | Carve out pre-existing IP; add license-back for client-specific derivatives |\n| Payment Terms | 9.4 | MEDIUM | Change to Net 30 payment terms |\n| Termination | 12.1 | HIGH | Add 30-day cure period for termination |\n| SLA Penalties | 14.3 | MEDIUM | Cap SLA penalties at 10% of monthly fees |\n| Change Orders | 15.2 | MEDIUM | Require written change orders signed by authorized representatives |\n| Indemnification | 7.3 | HIGH | Add mutual indemnification |\n| Dispute Resolution | 16.1 | MEDIUM | Add escalation before litigation |\n| Auto-Renewal | 3.2 | MEDIUM | Remove auto-renewal |\n| Resource Replacement | 5.4 | MEDIUM | Limit resource replacement rights |\n\n#### CTR-5002 -- Meridian Healthcare -- **REVIEW REQUIRED**\n\nNo clause evidence is packaged for this contract; no compliance conclusion can be made.\n\n#### CTR-5003 -- Atlas Financial Group -- **GAPS FOUND (3)**\n\n| Clause | Section | Severity | Required Action |\n|--------|---------|----------|-----------------|\n| Indemnification | 5.1 | HIGH | Add mutual indemnification clause |\n| Data Handling | 6.3 | MEDIUM | Add 90-day data destruction clause with certification |\n| Non-Compete | 11.2 | MEDIUM | Narrow scope to specific sub-sector or reduce to 6 months |\n\n#### CTR-5004 -- Orion Defense Systems -- **REVIEW REQUIRED**\n\nNo clause evidence is packaged for this contract; no compliance conclusion can be made.\n\n> Internal-policy screening only; this is not a legal or regulatory compliance determination.",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "Internal Policy Requirements",
        "REVIEW REQUIRED",
        "CTR-5002"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-04",
      "persona": "General Counsel",
      "onepager_promise": "Recommend amendments and negotiation strategies to strengthen contract positions and limit legal costs",
      "prompt": "Prepare the negotiation positions, fallbacks, and escalation points for the highest-risk agreements.",
      "assistant_response": "Here's the negotiation playbook for the two highest-risk agreements in the portfolio:\n\n## CTR-5001 \u2014 NovaTech Systems ($25M/36mo, risk 6.5/10)\n**Non-negotiable (6):**\n1. Liability cap \u2192 $10M\n2. Mutual indemnification\n3. Carve-outs: IP, data breach, gross negligence\n4. Protect pre-existing methodologies (IP)\n5. License-back for client-specific work\n6. Restrict client resale rights\n\n**Also push for:** narrow \"work product\" definition, Net 30 terms, 30-day cure period, SLA penalty cap (10% of monthly fees), written change-order requirement, pre-litigation escalation, drop auto-renewal, limit resource-replacement rights.\n\n- **Fallback:** $8.3M liability floor (tied to annual value) + mutual indemnification + critical carve-outs, or tiered caps by violation type.\n- **Escalation:** General Counsel if liability cap talks stall.\n\n## CTR-5003 \u2014 Atlas Financial Group ($12M/24mo, risk 5.2/10)\n**Non-negotiable (1):** Mutual indemnification (Sec. 5.1)\n\n**Preferred:** 90-day data destruction + certification clause (Sec. 6.3); narrow non-compete to a specific sub-sector or cut to 6 months (Sec. 11.2).\n\n- **Fallback:** accept current medium-risk terms if all high-risk items resolved.\n- **Escalation:** General Counsel if impasse persists.\n\nThese are draft positions for counsel review only \u2014 nothing here is legal advice or a sent amendment. Want the full redline/executive summary next?",
      "agent_logs": "[ContractRiskReviewAgent] ## Renegotiation Brief\n\n### CTR-5001 -- NovaTech Systems\n- **Value:** $25,000,000 over 36 months\n- **Risk score:** 6.5/10\n- **Governing law:** Delaware\n\n14 critical amendments required before signing. Top 6 are non-negotiable for risk protection.\n\n**Non-Negotiable Amendments (must resolve):**\n1. **Liability Protection:** Increase cap to $10M\n2. **Liability Protection:** Add mutual indemnification\n3. **Liability Protection:** Carve-outs: IP, data breach, gross negligence\n4. **IP Protection:** Protect pre-existing methodologies\n5. **IP Protection:** License-back for client-specific work\n6. **IP Protection:** Restrict client resale rights\n\n**All amendments by priority group:**\n\n*Liability Protection:*\n1. Increase cap to $10M (non-negotiable)\n2. Add mutual indemnification (non-negotiable)\n3. Carve-outs: IP, data breach, gross negligence (non-negotiable)\n\n*IP Protection:*\n4. Protect pre-existing methodologies (non-negotiable)\n5. License-back for client-specific work (non-negotiable)\n6. Restrict client resale rights (non-negotiable)\n7. Define \"work product\" narrowly\n\n*Payment & Termination:*\n8. Change to Net 30 payment terms\n9. Add 30-day cure period for termination\n10. Cap SLA penalties at 10% of monthly fees\n\n*Additional Amendments:*\n11. Require written change orders\n12. Escalation before litigation\n13. Remove auto-renewal\n14. Limit resource replacement rights\n\n**Fallback Position:** Minimum $8.3M liability (annual value) with mutual indemnification and critical carve-outs\n**Alternative:** Tiered caps by violation type\n- Escalation path: General Counsel review if impasse on liability cap\n\n### CTR-5003 -- Atlas Financial Group\n- **Value:** $12,000,000 over 24 months\n- **Risk score:** 5.2/10\n- **Governing law:** California\n\n**Non-Negotiable Amendments (must resolve):**\n1. **Indemnification** (Section 5.1): Add mutual indemnification clause\n\n**Preferred Amendments:**\n1. **Data Handling** (Section 6.3): Add 90-day data destruction clause with certification\n2. **Non-Compete** (Section 11.2): Narrow scope to specific sub-sector or reduce to 6 months\n- Fallback: accept current value on MEDIUM items if all HIGH items resolved\n- Escalation path: General Counsel review if impasse on liability cap\n\nSource: [Legal Benchmarking + Industry Comparisons] (synthetic)\n\n> Draft positions for authorized counsel review; no amendment has been sent or accepted.\n\nReady for the redline document?",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "Non-Negotiable Amendments",
        "General Counsel",
        "Draft positions"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-05",
      "persona": "Commercial Attorney",
      "onepager_promise": "Perform comprehensive contract analysis to accelerate reviews and highlight critical risks",
      "prompt": "Legal just sent over the NovaTech Systems master services agreement. Can you review it before our signing meeting tomorrow?",
      "assistant_response": "Here's the quick-hit summary from the review (14 amendments recommended, risk score 6.5/10 medium-high) \u2014 I'd flag this one before tomorrow:\n\n**Top 6 critical issues:**\n1. **Liability cap** \u2013 capped at only 12 months' fees ($2-8M), way out of proportion to a $25M/3yr deal\n2. **IP ownership** \u2013 all work product assigns to NovaTech, no carve-outs for your pre-existing IP/tools\n3. **Payment terms** \u2013 Net 60 instead of your standard Net 30\n4. **Termination** \u2013 no cure period; any breach = immediate termination\n5. **SLA penalties** \u2013 uncapped, could exceed monthly fees entirely\n6. **Change orders** \u2013 verbal approval is accepted, which is a scope-control risk\n\nGiven the size of this deal and the number of critical issues, I'd strongly recommend this goes to counsel before signing \u2014 not a rubber-stamp situation.\n\nWant me to pull the full liability breakdown, the IP ownership details, or the complete renegotiation brief (priorities/fallbacks/non-negotiables) to prep for the meeting?",
      "agent_logs": "[ContractRiskReviewAgent] I've analyzed the 47-page NovaTech Systems MSA and identified significant risk exposure requiring 14 amendments before signing. Risk rating: 6.5/10 (medium-high).\n\n## Contract Overview\n\n| Element | Details |\n|---|---|\n| Agreement type | Master Services Agreement |\n| Total value | $25M over 36 months (3 years) |\n| Client | NovaTech Systems Inc |\n| Governing law | Delaware |\n| Pages analyzed | 47 |\n| Risk score | 6.5/10 (Medium-High) |\n\n**Critical Issues Identified (6):**\n- Liability exposure: Cap limited to prior 12 months fees ($2-8M)\n- IP ownership: ALL work product assigned to client\n- Payment terms: Net 60 vs standard Net 30\n- Termination: No cure period, immediate for any breach\n- SLA penalties: Uncapped, could exceed monthly fees\n- Change orders: Verbal approval accepted (risky)\n\nSource: [Synthetic contract record + Contract Analysis]\n\nReview support only; contract decisions require authorized legal counsel.\n\nWant details on the liability exposure?",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "Contract Overview",
        "6.5/10",
        "14 amendments"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-06",
      "persona": "Commercial Attorney",
      "onepager_promise": "Evaluate liability exposure and IP provisions to identify gaps and ensure complete financial protections",
      "prompt": "What specifically is wrong with the liability provisions in the NovaTech agreement?",
      "assistant_response": "Here's the core problem with Section 7.1 (Liability):\n\n**The cap is too low and badly structured:**\n- It's set at \"fees paid in preceding 12 months\" \u2014 meaning $2M-$8M depending on contract stage\n- But potential damages are estimated at $10-20M, leaving a $2-18M shortfall\n- Industry standard would be annual contract value ($8.3M) minimum, ideally $10M\n\n**No carve-outs for the stuff that matters most:**\n- IP indemnity claims\n- Data breach incidents\n- Gross negligence\n\nThese typically get excluded from the cap entirely in well-drafted MSAs \u2014 here they're just swept in with everything else.\n\n**It's one-sided (Section 7.3):** NovaTech requires *us* to indemnify *them*, but there's no reciprocal indemnification flowing back. That's an unusual imbalance for a deal this size.\n\n**Insurance mismatch:** Current E&O coverage doesn't line up with the real exposure once you look at the cap gap.\n\nBottom line: this needs to go to counsel before signing \u2014 not a minor redline, a structural renegotiation point.\n\nWant me to pull the IP ownership issues next?",
      "agent_logs": "[ContractRiskReviewAgent] The liability cap is dangerously low and one-sided: we could face $10M+ in damages with only $2M protection, and they don't indemnify us at all.\n\n## Liability Problems (Section 7.1)\n\n**Current Cap:** \"Fees paid in preceding 12 months\"\n- Minimum exposure: $2M (early project)\n- Maximum exposure: $8M (later stages)\n- Gap to damages: could be $2-18M shortfall (against $10-20M potential damages)\n\n**Industry Standards:**\n- Minimum: Annual contract value ($8.3M)\n- Preferred: Greater of annual value or $10M\n- **Our recommendation: $10M with carve-outs**\n\n**Missing Protections:**\n- No carve-outs for IP indemnity\n- No carve-outs for data breach\n- No carve-outs for gross negligence\n- One-sided (Section 7.3): We indemnify them, they don't indemnify us\n\n**Insurance Gap:** Current E&O coverage insufficient for $10M+ exposure\n\nSource: [Contract Benchmarking + Insurance Analysis] (synthetic)\n\n> Draft positions for authorized counsel review; no amendment has been sent or accepted.\n\nWhat about the IP ownership issues?",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "$10M with carve-outs",
        "$8.3M",
        "Insurance Gap"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-07",
      "persona": "Commercial Attorney",
      "onepager_promise": "Evaluate liability exposure and IP provisions to identify gaps and ensure complete financial protections",
      "prompt": "Show me the IP ownership problems in the NovaTech agreement.",
      "assistant_response": "Here's the core problem in Section 8.2:\n\n- **Blanket assignment** \u2014 ALL IP (including improvements/derivatives) goes to the client, no exceptions.\n- **No pre-existing IP carve-out** \u2014 your background methods/tools built before this engagement get swept in too.\n- **No license-back** \u2014 you can't reuse anything you build, even your own general-purpose accelerators.\n- **No use restriction** \u2014 client could resell or hand your work to competitors.\n\n**Fixes to push for:** carve out pre-existing IP, add a license-back for reusable work product, restrict client use (no resale), and narrow the definition of \"work product\" so it doesn't capture everything by default.\n\nWant me to pull the other flagged risks (liability, payment, termination, etc.) or go straight to the full renegotiation brief?",
      "agent_logs": "[ContractRiskReviewAgent] Section 8.2 assigns ALL intellectual property to the client with no protection for our pre-existing methods or license-back for derivatives: they could sell our accelerators to competitors.\n\n## IP Ownership Issues\n\n**Current Language (Section 8.2):**\n- ALL work product assigned to client\n- Includes improvements and derivatives\n- No distinction for pre-existing IP\n- No license-back provision\n- No restrictions on client use\n\n**Risk Scenario:**\n- We develop valuable accelerator during engagement\n- Client owns it completely\n- Client can use it with our competitors\n- Client can sell it in the market\n- We can't reuse our own innovation\n\n**Required Protections:**\n- Carve-out for pre-existing methodologies\n- License-back for client-specific work\n- Restriction: Client use only, no resale\n- Define \"work product\" narrowly\n\nSource: [IP Risk Analysis + Standard Templates] (synthetic)\n\n> Draft positions for authorized counsel review; no amendment has been sent or accepted.\n\nWhat other risks did you find?",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "Section 8.2",
        "Risk Scenario",
        "License-back for client-specific work"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-08",
      "persona": "Legal Operations Director",
      "onepager_promise": "Perform comprehensive contract analysis to accelerate reviews and highlight critical risks",
      "prompt": "What other risk factors did you find beyond liability and IP?",
      "assistant_response": "Beyond liability and IP, five more issues stand out in CTR-5001:\n\n- **Payment terms**: Net 60 instead of Net 30 \u2014 delays ~$1.4M in cash flow\n- **Termination**: Immediate termination rights with no cure period \u2014 risks losing the full $25M if a minor breach triggers it\n- **SLA penalties**: Uncapped \u2014 could exceed monthly fees entirely\n- **Change orders**: Verbal approval allowed \u2014 opens the door to scope creep with no paper trail\n- **Dispute resolution**: Litigation-first clause \u2014 high legal cost exposure vs. mediation/arbitration\n- Also flagged: auto-renewal with a locked-in rate (no price adjustment), and the client's unilateral right to swap out your team members\n\nWant me to pull the full renegotiation brief with priorities and fallback positions for these?",
      "agent_logs": "[ContractRiskReviewAgent] 5 more significant issues: payment delays, immediate termination rights, uncapped penalties, verbal change orders, and unfavorable dispute resolution.\n\n## Additional Risks\n\n| Risk | Current Terms | Impact |\n|---|---|---|\n| Payment | Net 60 days | $1.4M delayed cash flow |\n| Termination | Immediate, no cure | Loss of $25M revenue |\n| SLA penalties | Uncapped | Could exceed monthly fees |\n| Change orders | Verbal OK | Scope creep exposure |\n| Disputes | Litigation-first | High legal costs |\n\n- **Cash Flow Impact:** Net 60 delays $1.4M on average (two months of $694,444 monthly fees) vs Net 30 standard\n- **Termination Risk:** No 30-day cure period means instant contract loss for a minor breach\n- **Auto-Renewal:** Yes, with an unfavorable rate lock preventing price adjustments\n- **Resource Control:** Client has unilateral right to replace our team members\n\nSource: [Payment Analysis + Risk Modeling] (synthetic)\n\n> Draft positions for authorized counsel review; no amendment has been sent or accepted.\n\nWhat amendments are you recommending?",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "$1.4M delayed cash flow",
        "Litigation-first",
        "Auto-Renewal"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    },
    {
      "case_id": "CRR-09",
      "persona": "General Counsel",
      "onepager_promise": "Recommend amendments and negotiation strategies to strengthen contract positions and limit legal costs",
      "prompt": "Generate the redline and an executive summary for our legal team.",
      "assistant_response": "Here's the draft package for CTR-5001 (NovaTech MSA) \u2014 nothing sent or uploaded yet.\n\n**Redline (14 tracked changes)** covering:\n- **Liability** \u2014 raise cap to $10M, add mutual indemnification, carve-outs for IP/data breach/gross negligence\n- **IP** \u2014 protect provider's pre-existing methodologies, license-back for client-specific work, narrow \"work product\" definition, restrict resale\n- **Payment/Termination** \u2014 Net 60\u219230, add 30-day cure period, cap SLA penalties at 10%, require written change orders\n- **Other** \u2014 escalation-before-litigation, remove auto-renewal, limit unilateral resource replacement\n\n**Executive memo (3-page outline):**\n1. Risk summary \u2014 $25M/36-month deal, risk score 6.5/10\n2. Rationale for all 14 amendments\n3. Negotiation boundaries: target $10M cap w/ carve-outs, floor $8.3M w/ mutual indemnification, fallback to tiered caps by violation type\n\nThis is draft text for your legal team to put into Word/send to counsel \u2014 I haven't filed, sent, or flagged anything, and this isn't legal advice. Want me to pull the full liability or IP clause-by-clause detail to attach as backup?",
      "agent_logs": "[ContractRiskReviewAgent] Redlined MSA and executive memo drafted for your legal team, ready for you to review and upload to your contract workspace. Nothing has been uploaded, sent or flagged.\n\n## Deliverables (drafts)\n\n- **Redlined MSA:** 14 tracked changes (draft text below, ready for Word)\n- **Executive memo:** 3-page risk summary with rationale (outline below)\n- **Fallback positions:** Tiered negotiation strategy\n- **Comparable terms:** Industry contract references\n- **Insurance review:** $10M E&O coverage to raise with your broker\n\n### Redline: 14 tracked changes\n\n| # | Change | Original | Proposed |\n|---|---|---|---|\n| 1 | Increase cap to $10M | Cap = fees paid in preceding 12 months | Cap = $10,000,000 per claim |\n| 2 | Add mutual indemnification | Provider indemnifies client only | Each party indemnifies the other |\n| 3 | Carve-outs: IP, data breach, gross negligence | No carve-outs | IP indemnity, data breach and gross negligence sit outside the cap |\n| 4 | Protect pre-existing methodologies | ALL work product assigned to client | Pre-existing IP and methodologies remain with provider |\n| 5 | License-back for client-specific work | No license-back | Provider receives a license-back to client-specific derivatives |\n| 6 | Restrict client resale rights | No restrictions on client use | Client use only; no resale or transfer to third parties |\n| 7 | Define \"work product\" narrowly | Work product includes improvements and derivatives | Work product = deliverables named in each SOW |\n| 8 | Change to Net 30 payment terms | Net 60 | Net 30 |\n| 9 | Add 30-day cure period for termination | Immediate termination for any breach | 30-day written cure period before termination |\n| 10 | Cap SLA penalties at 10% of monthly fees | Uncapped SLA penalties | SLA penalties capped at 10% of monthly fees |\n| 11 | Require written change orders | Verbal approval accepted | Signed written change orders only |\n| 12 | Escalation before litigation | Litigation-first | Executive escalation, then mediation, before litigation |\n| 13 | Remove auto-renewal | Auto-renewal with rate lock | Renewal by mutual written agreement with rate review |\n| 14 | Limit resource replacement rights | Client may replace team members unilaterally | Replacement for documented cause with 15 days notice |\n\n### Executive memo outline (3 pages)\n1. Risk summary: NovaTech Systems MSA, $25M over 36 months, risk 6.5/10\n2. Rationale for the 14 amendments (liability, IP, payment and termination, additional)\n3. Negotiation boundaries and fallback positions\n\n**Key Talking Points:**\n- Risk score: 6.5/10 requires amendments\n- Liability exposure: $2-18M gap\n- IP risk: Complete ownership transfer\n- Cash flow impact: $1.4M delayed\n- Termination: No cure period\n\n**Negotiation Strategy:**\n- Target: $10M liability cap with carve-outs\n- Minimum: $8.3M with mutual indemnification\n- Alternative: Tiered caps by violation type\n\nSource: [Synthetic contract record + Legal Benchmarking]\n\n> Draft positions for authorized counsel review; no amendment has been sent or accepted. Synthetic draft for counsel; this is not legal advice.",
      "expected_agent": "ContractRiskReviewAgent",
      "must_include": [
        "14 tracked changes",
        "Tiered caps by violation type",
        "Nothing has been uploaded"
      ],
      "model": "claude-sonnet-5",
      "requested_model": "claude-sonnet-5",
      "passed": true
    }
  ]
}